| Name | melanoma antigen family A9B |
| Description | MAGEA9B is a duplication of the MAGEA9 gene (MIM 300342) on chromosome Xq28. The 2 copies are separated by about 194 kb (Hartz, 2009).[supplied by OMIM, Mar 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n MAGE‐A9 is an oncogenic cancer/testis antigen that exhibits highly restricted expression in normal tissues yet is aberrantly activated in a broad spectrum of human malignancies—including bladder, esophageal, hepatocellular, lung, breast, renal, and even liposarcoma—thereby serving as both a prognostic biomarker and a promising target for immunotherapy."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": " In many tumors, high levels of MAGE‐A9 expression correlate with more advanced grade, nodal and distant metastasis, recurrence, and overall poor survival."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_f", "ref": "3"}, {"type": "fg_fs", "start_ref": "5", "end_ref": "7"}]}, {"type": "t", "text": " Functionally, MAGE‐A9 promotes tumor progression by enhancing cell proliferation, migration, invasion, and chemoresistance, and it may help maintain cancer stem cell properties, as observed in liver tumors"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}, {"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "; in lung adenocarcinoma, its suppression can trigger apoptosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Mechanistically, MAGE‐A9 has been implicated in the modulation of hypoxic responses through its interaction with factors such as prolyl hydroxylase (which regulates HIF‐1α stability)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": ", and its transcription can be regulated both epigenetically—through promoter demethylation"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "—and post‐transcriptionally via microRNAs."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": " Notably, owing to its tumor‐restricted and immunogenic nature, MAGE‐A9-derived peptides have been harnessed to induce cytotoxic T lymphocyte responses in several tumor types"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": ", underscoring its potential value in cancer immunotherapy. Collectively, these multifaceted roles of MAGE‐A9 as a driver of aggressive tumor phenotypes and as a target for immune‐based strategies highlight its clinical significance in both prognosis and therapeutic intervention.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Alain Bergeron, Valérie Picard, Hélène LaRue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.24503"}], "href": "https://doi.org/10.1002/ijc.24503"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19533752"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19533752"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Sid P Kerkar, Zeng-Feng Wang, Jerzy Lasota, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunother (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/CJI.0000000000000119"}], "href": "https://doi.org/10.1097/CJI.0000000000000119"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27070449"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27070449"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xuefeng Gu, Maoying Fu, Zhijun Ge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep06625"}], "href": "https://doi.org/10.1038/srep06625"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25315972"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25315972"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Liang Han, Bin Jiang, Hao Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2014)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25400753"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25400753"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Siya Zhang, Xiaolu Zhai, Gui Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25755744"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25755744"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Weipeng Zhan, Zhaoqin Zhang, Yan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic value of MAGE-A9 expression in patients with colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Res Hepatol Gastroenterol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.clinre.2015.08.005"}], "href": "https://doi.org/10.1016/j.clinre.2015.08.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26516058"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26516058"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xiaohua Chen, Sina Cai, Liping Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of the function of MAGE-A in esophageal carcinoma by bioinformatics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Medicine (Baltimore) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MD.0000000000015774"}], "href": "https://doi.org/10.1097/MD.0000000000015774"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31124967"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31124967"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Youping Wei, Yanqin Wang, Jing Gong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2017.4198"}], "href": "https://doi.org/10.3892/ijo.2017.4198"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29138811"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29138811"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Olga Aprelikova, Silvia Pandolfi, Sean Tackett, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-0811"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-0811"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19147576"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19147576"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Valérie Picard, Alain Bergeron, Hélène Larue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MAGE-A9 mRNA and protein expression in bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.22282"}], "href": "https://doi.org/10.1002/ijc.22282"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17290406"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17290406"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Lijiang Yu, Xiaolin Shao, Lingli Huo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Non-Coding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Cell Proliferation and Migration by Regulating miR-143-3p and MAGE Family Member A9 (MAGEA9) in Oral Squamous Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Sci Monit (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.12659/MSM.924187"}], "href": "https://doi.org/10.12659/MSM.924187"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32879299"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32879299"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Nicolás Herbert, Axel Haferkamp, Hubertus F Schmitz-Winnenthal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Concomitant tumor and autoantigen vaccination supports renal cell carcinoma rejection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.0902683"}], "href": "https://doi.org/10.4049/jimmunol.0902683"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20548033"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20548033"}]}]}]}
|
| NCBI Gene ID | 728269 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MAGEA9B has 1,047 functional associations with biological entities spanning 7 categories (molecular profile, chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 32 datasets.
Click the + buttons to view associations for MAGEA9B from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MAGEA9B gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of MAGEA9B gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of MAGEA9B gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with MAGEA9B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MAGEA9B gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with MAGEA9B gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with MAGEA9B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with MAGEA9B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with MAGEA9B gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MAGEA9B gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MAGEA9B gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MAGEA9B gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of MAGEA9B gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of MAGEA9B gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of MAGEA9B gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of MAGEA9B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MAGEA9B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MAGEA9B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MAGEA9B gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting MAGEA9B gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MAGEA9B gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for MAGEA9B from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MAGEA9B gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MAGEA9B gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of MAGEA9B gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MAGEA9B gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MAGEA9B gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of MAGEA9B gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of MAGEA9B gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MAGEA9B protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with MAGEA9B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with MAGEA9B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |